After the outstanding success of the last two conferences in Shanghai and Beijing, China, which was attended by over 600 eminent scientists and 1000 participants every time, the third congress in Singapore promises to be an even larger event emphasizes on the practical, actionable ideas for accelerating the cancer research and therapy. Plenary, concurrent, poster sessions and exhibition focusing on the full spectrum of latest research will be helpful for all delegates from academia and industry to deeply understand the novel technologies and current situation in cancer field.